Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents

Journal of Chemotherapy

Volumn 24, Issue 4, 2012, Pages 240-242

  Bassetti, Matteo ^a   Nicco, Elena ^a   Giacobbe, Daniele Roberto ^a   Marchese, Anna ^a   Coppo, Erika ^a   Barbieri, Ramona ^a   Viscoli, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; C REACTIVE PROTEIN; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE;

ADULT; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AUTOIMMUNE THYROIDITIS; BACTERIAL ENDOCARDITIS; BACTERIUM ISOLATION; BICUSPID AORTIC VALVE; BLOOD CULTURE; BLOOD PRESSURE MEASUREMENT; BODY TEMPERATURE; BORDETELLA; BORDETELLA HOLMESII; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIASTOLIC HEART MURMUR; DISK DIFFUSION; FATIGUE; FEVER; FOLLOW UP; GENE INSERTION SEQUENCE; HEART AUSCULTATION; HEART LEFT VENTRICLE OVERLOAD; HEART RATE; HOSPITAL ADMISSION; HUMAN; ITALY; LETTER; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; SAINT JUDE HEART VALVE PROSTHESIS; SEQUENCE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSTHORACIC ECHOCARDIOGRAPHY;

AZATHIOPRINE; BORDETELLA; BORDETELLA INFECTIONS; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; ITALY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDNISONE; TREATMENT OUTCOME;

EID: 84866261717     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947812Y.0000000009     Document Type: Letter

References (19)

1. Weyant RS, Hollis DG, Weaver RE, Amin MF, Steigerwalt AG, O'Connor SP, et al. Bordetella holmesii sp. nov., a new gram negative species associated with septicemia. J Clin Microbiol. 1995;33:1-7.
2. Lindquist SW, Weber DJ, Mangum ME, Hollis DG, Jordan J. Bordetella holmesii sepsis in an asplenic adolescent. Pediatr Infect Dis J. 1995;14:813-5.
3. Tang Y-W, Hopkins MK, Kolbert CP, Hartley PA, Severance PJ, Persing DH. Bordetella holmesii-like organisms associated with septicemia, endocarditis, and respiratory failure. Clin Infect Dis. 1998;26:389-92.
4. Morris JT, Myers M. Bacteremia due to Bordetella holmesii. Clin Infect Dis. 1998;27:912e3.
5. Njamkepo E, Delisle F, Hagege I, Gerbaud G, Guiso N. Bordetella holmesii isolated from a patient with sickle cell anemia: analysis and comparison with other Bordetella holmesii isolates. Clin Microbiol Infect. 2000;6:131-6.
6. Greig JR, Gunda SS, Kwan JT. Bordetella holmesii bacteraemia in an individual on haemodialysis. Scand J Infect Dis. 2001;33:716-7.
7. Russell FM, Davis JM, Whipp MJ, Janssen PH, Ward PB, Vyas JR, et al. Severe Bordetella holmesii infection in a previously healthy adolescent confirmed by gene sequence analysis. Clin Infect Dis. 2001;33:129-30.
8. Shepard CW, Daneshvar MI, Kaiser RM, Ashford DA, Lonsway D, Patel JB, et al. Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clin Infect Dis. 2004;38:799-804.
9. Panagopoulos MI, Saint Jean M, Brun D, Guiso N, Bekal S, Ovetchkine P, et al. Bordetella holmesii bacteremia in asplenic children: report of four cases initially misidentified as Acinetobacter lwoffii. J Clin Microbiol. 2010;48:3762-4.
10. Morpeth S, Murdoch D, Christopher H, Karchmer AW, Pappas P, Levine D, et al. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829-35.
11. Chakravorty S, Helb D, Burday M, Connel N, Alland D. A detailed analysis of 16S ribosomia RNA gene segments for the diagnosis of pathogenic bacteria. J Microbiol Methods. 2007;69:330-9.
12. Roorda L, Buitenwerf J, Ossewaarde JM, Van der Zee A. A real-time PCR assay with improved specificity for detection and discrimination of all clinically relevant Bordetella species by the presence and distribution of three Insertion Sequence elements. BMC Res Notes. 2011;4:11.
13. Loeffelholz MJ, Sanden GN. Bordetella. In: Manual of clinical microbiology, 9th edition. Murray PR, Barona EJ, Jorgenseng JH, Landry ML, Pfaller MA, editors. Washington, DC: ASM Press; 2007. p. 803-14.
14. Cockerill FR. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. M45-A2. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI); 2010.
15. Cockerill FR. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement. M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI); 2011.
16. Livermore DM. Determinants of the activity of β-lactamase inhibitor combinations. J Antimicrob Chemother. 1993;31 Suppl A:9-21.
17. Yih WK, Silva EA, Ida J, Harrington N, Lett SM, George H. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis. 1999;5:441-3.
18. Pines A, Kaplinsky N, Olchovsky D, Holtzman E, Frankl O. Hyposplenism in systemic lupus erythematosus. Br J Rheumatol. 1983;22:176-8.
19. Neo Y, Li R, Howe J, Hoo R, Pant A, Ho S, et al. Evidence for an intact polysaccharide capsule in Bordetella pertussis. Microbes Infect. 2010;12:238-45.